![](/img/cover-not-exists.png)
OC-097 The novel gastrin/CCK2 receptor antagonist YF476 induces clinical responses and is well tolerated in patients with type I gastric neuroendocrine tumours
Moore, A R, Ball, L, Boyce, M, Varro, A, Pritchard, D MVolume:
61
Language:
english
Journal:
Gut
DOI:
10.1136/gutjnl-2012-302514a.97
Date:
July, 2012
File:
PDF, 69 KB
english, 2012